Digital platform for patient feedback in psychiatry
Part of Mental health clinical trials.
This study tests a digital platform called MonPsy&Moi that lets you share your own experiences and feedback about your psychiatric care. It aims to improve how doctors understand your needs and tailor treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in France.
- You are between 18 and 65 years old.
- You have a diagnosis of schizophrenia, bipolar disorder, or major depression.
- You are currently receiving care at one of the 12 participating psychiatric hospitals.
- You have a valid email address and can read French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a French version of a questionnaire (PERMA-Profiler) works reliably for measuring different parts of wellbeing. It may help French-speaking people and clinicians use the tool in future research and care.
This study tests a smartphone-based emotional monitoring device (EMOCARE) to see if it can accurately measure your mood compared to a standard depression questionnaire. It may help researchers find a simpler way to track depression symptoms.
This trial tests a smartphone app that helps doctors manage depression in everyday life. It may help improve how care is tracked and adjusted soon after starting antidepressant treatment.
This trial studies a digital solution (Dalia) for people with depression who are starting or changing their antidepressant. It aims to see if the solution helps with mood and well-being.
This study looks at how people with bipolar disorder or depression process social situations, memory, and thinking. It compares patients, their relatives, and healthy volunteers to better understand these conditions.
This trial tests whether a digital health app (with “virtual agents,” like guided prompts/support) can improve people’s health outcomes. You may help the study by using the app and completing its questionnaires.
Hear when a new Schizophrenia Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.